– ISRAEL, Herzliya – Cognyte Software Ltd. (Nasdaq: CGNT), a global leader in investigative analytics software, announced the appointment of Matthew O’Neill and Nurit Benjamini to its Board as new Independent Directors effective respectively on March 1, 2025, and March 31, 2025.
“We are pleased to welcome Matthew O’Neill and Nurit Benjamini as our two newest board members,” said Board Chairman, Earl Shanks. “These latest appointments reflect our commitment to further strengthen the board with deep industry and business experience. Matthew brings significant domain expertise in security and a strong understanding of U.S. federal agency practices and procedures. Nurit has extensive experience working in the software sector, where she has led finance, operations, legal and strategic initiatives across different roles and domains. We are excited to have both Matthew and Nurit with us as we continue to drive consistent long-term growth at Cognyte.”
Richard Nottenburg will step down from his board position effective March 31, 2025.
About Matthew O’Neill
Having served with the United States Secret Service for over two decades, Matthew O’Neill brings significant law enforcement, government, financial crimes, and security experience, along with established relationships within these communities.
Matthew O’Neill served until December 2023 as the Deputy Special Agent in Charge of Cyber Operations at the United States Secret Service, where he directed the agency’s global cyber investigative strategies and oversaw efforts to dismantle transnational criminal networks. During his tenure, he served as the Director of the Asset Forfeiture Branch and as the Director of the Global Investigative Operations Center, where he established the Secret Service’s first agency-wide criminal investigative fusion center.
Matthew O’Neill holds certifications from Carnegie Mellon University and American University and earned his Bachelor of Science degree from James Madison University. He currently serves as Co-Founder and Partner at 5OH Consulting LLC.
About Nurit Benjamini
Nurit Benjamini has more than 20 years of experience as CFO in leading software companies, overseeing financial reporting for a diverse group of U.S.-listed technology firms. Together, these two directors are well-aligned with Cognyte’s strategic goals of growing its business and expanding its North American presence.e
Nurit Benjamini is a Partner and CFO at F2 Venture Capital, bringing over 20 years of experience as a CFO for leading software companies, including CrazyLabs Ltd., Wix (Nasdaq: WIX), CopperGate Communications Ltd. and Compugen (Nasdaq: CGEN). Throughout her career, she has played a pivotal role in leading technology companies through fundraising, M,&A and IPO processes. Currently, she serves as an external director at Caesarstone Ltd. (Nasdaq: CSTE), having previously served as a board member of BioLineRx (Nasdaq: BLRX) and Allot Ltd. (Nasdaq: ALLT).
Nurit Benjamini holds a Bachelor of Arts degree in economics and business and a Master of Business Administration degree in finance, both from Bar Ilan University, Israel.
About Cognyte Software Ltd.
Cognyte Software Ltd. is a global leader in investigative analytics software that empowers a variety of government and other organizations with Actionable Intelligence for a Safer World. Our open interface software is designed to help customers accelerate and improve the effectiveness of investigations and decision-making. Hundreds of customers rely on our solutions to accelerate and conduct investigations and derive insights, with which they identify, neutralize, and tackle threats to national security and address different forms of criminal and terror activities.
For more: https://www.cognyte.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.